Leaflet THELIN 100mg film-coated tablets

Product code:
W51774005
Quantity:
28
Indicated for:
pulmonary arterial hypertension
Route of administration:
oral
Substance:
sitaxentan (antihypertensive)
ATC
C02KX03 — Cardiovascular system | Other antihypertensives | Antihypertensives for pulmonary arterial hypertension
Sitaxentan is a selective endothelin receptor A antagonist used in the treatment of pulmonary arterial hypertension (PAH). It works by blocking the vasoconstrictive and proliferative effects of endothelin-1, a mediator involved in the pathogenesis of PAH, thereby reducing pulmonary arterial pressure and improving cardiac function.

Sitaxentan is administered orally, usually once daily, and is indicated for patients with WHO functional class II or III PAH. Treatment can lead to an increase in exercise capacity and improvement in symptoms such as dyspnea and fatigue.

Common side effects include headache, nausea, nasal congestion, and elevated liver enzymes. In rare cases, severe adverse reactions such as hepatotoxicity may occur. Regular monitoring of liver function is essential during treatment.

Sitaxentan is a valuable therapeutic option for patients with pulmonary arterial hypertension, contributing to improved quality of life and reduced disease progression.

General data about THELIN 100mg

Substance:
sitaxentan
Date of latest medicines list:
01-07-2013
Product code:
W51774005
Concentration:
100mg
Pharmaceutical form:
film-coated tablets
Quantity:
28
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.